z-logo
Premium
Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD‐driven salvage approach
Author(s) -
Guolo Fabio,
Minetto Paola,
Clavio Marino,
Miglino Maurizio,
Colombo Nicoletta,
Cagnetta Antonia,
Cea Michele,
Marcolin Riccardo,
Todiere Andrea,
Ballerini Filippo,
Gobbi Marco,
Lemoli Roberto Massimo
Publication year - 2019
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16116
Subject(s) - minimal residual disease , npm1 , medicine , myeloid leukaemia , oncology , mutation , salvage therapy , residual , disease , leukemia , genetics , chemotherapy , biology , karyotype , gene , algorithm , chromosome , computer science

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom